,PDB,resolution,year,affinity,kd/ki,embedding_factor,complex_nha,lig_nha,distB,title,seq,TMScore,sess_id,distA,difference
0,1mq5,2.1,2003,9.0,Ki=1nM,0.7939330355396929,2427,34,17.424027130828446,CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(4-CHLOROPHENYL) 2 AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- 3 THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA,IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK,1.0,C4001MQ5,17.38449395510836,-0.0395331757200843
1,2idw,1.1,2006,8.89,Ki=1.3nM,0.8998886021574316,1803,38,4.884697378730111,CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A POTEN 2 NON-PEPTIDE INHIBITOR (UIC-94017),PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYDQIIIEIAGHKAIGTVLVGPTPANIIGRNLLTQIGATLNF,1.0,C4002IDW,5.254564493534078,0.3698671148039665
2,1swg,1.8,1998,7.36,Kd=43.9nM,0.8329395740465577,3812,16,15.243051847287257,CIRCULAR PERMUTED STREPTAVIDIN E51/A46 IN COMPLEX WITH BIOTIN,MESRYVLTGRYDSAPATDGSGTALGWTVAWKNNYRNAHSATTWSGQYVGGAEARINTQWLLTSGTTEANAWKSTLVGHDTFTKVKPSAASGGGSAEAGITGTWYNQLGSTFIVTAGADGALTGTYESA,0.8577231929705511,C4001SWG,15.0046169312231,-0.2384349160641559
3,1gpn,2.35,2002,6.48,Ki=0.334uM,0.9797910097640482,4442,19,7.8200090407098735,STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH HUPERZINE B AT 2.35A 2 RESOLUTION,DDHSELLVNTKSGKVMGTRVPVLSSHISAFLGIPFAEPPVGNMRFRRPEPKKPWSGVWNASTYPNNCQQYVDEQFPGFSGSEMWNPNREMSEDCLYLNIWVPSPRPKSTTVMVWIYGGGFYSGSSTLDVYNGKYLAYTEEVVLVSLSYRVGAFGFLALHGSQEAPGNVGLLDQRMALQWVHDNIQFFGGDPKTVTIFGESAGGASVGMHILSPGSRDLFRRAILQSGSPNCPWASVSVAEGRRRAVELGRNLNCNLNSDEELIHCLREKKPQELIDVEWNVLPFDSIFRFSFVPVIDGEFFPTSLESMLNSGNFKKTQILLGVNKDEGSFFLLYGAPGFSKDSESKISREDFMSGVKLSVPHANDLGLDAVTLQYTDWMDDNNGIKNRDGLDDIVGDHNVICPLMHFVNKYTKFGNGTYLYFFNHRASNLVWPEWMGVIHGYEIEFVFGLPLVKELNYTAEEEALSRRIMHYWATFAKTGNPNEPHSQESKWPLFTTKEQKFIDLNTEPMKVHQRLRVQMCVFWNQFLPKLLNATAC,0.9187483447905744,C4001GPN,9.749885680569124,1.9298766398592502
4,1ws4,1.9,2005,3.0,Kd=1.00mM,0.7098055031251429,4875,13,35.713115389295126,CRYSTAL STRUCTURE OF JACALIN- ME-ALPHA-MANNOSE COMPLEX: PROMISCUITY VS 2 SPECIFICITY,GKAFDDGAFTGIREINLSYNKETAIGDFQVVYDLNGSPYVGQNHVSFITGFTPVKISLDFPSEYIMEVSGYTGNVSGYVVVRSLTFKTNKKTYGPYGVTSGTPFNLPIENGLIVGFKGSIGYWLDYFSMYLSL,1.0,C4001WS4,35.900462554143296,0.1873471648481697
5,1lpz,2.4,2003,7.6,Ki=25nM,0.8239368452439393,2116,32,13.502681282457374,CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41.,EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER,1.0,C4001LPZ,13.4018259924033,-0.10085529005407423
6,2a8g,1.99,2006,3.69,Kd=205uM,0.8661608350199298,3903,19,15.157853520764956,STRUCTURE OF AVIDIN IN COMPLEX WITH THE LIGAND DEOXYGUANOSINE,KCSLTGKWTNDLGSNMTIGAVNSRGEFTGTYTTAVTATSNEIKESPLHGTENTINKRTQPTFGFTVNWKFSESTTVFTGQCFIDRNGKEVLKTMWLLRSSVNDIGDDWKATRVGINIFTRLRTQKE,0.9917355371900828,C4002A8G,15.818062965769968,0.6602094450050124
7,1y3n,1.6,2005,5.55,Kd=2.8uM,0.9071553208017624,4704,24,6.172566187964076,"STRUCTURE OF ALGQ1, ALGINATE-BINDING PROTEIN, COMPLEXED WITH AN 2 ALGINATE DISACCHARIDE",REATWVTEKPLTLKIHMHFRDKWVWDENWPVAREVARLTNVKLVGVANRAATNSQEQFNLMMASGQLPDIVGGDNLKDKFIRYGMEGAFIPLNKLIDQNAPNLKAFFKTHPEVQRAITAPDGNIYYLPYVPDGLVSRGYFIRQDWLDKLHLKTPQTVDELYTVLKAFKEKDPNGNGKADEIPFINRDPEEVFRLVNFWGARSTGSNTWMDFYVENGKIKHPFAEVAFKDGIKHVAQWYKEGLIDPEIFTRKARSREQTFGNNIGGMTHDWFASTALFNDALSKNIPGFKLVPMAPPINSKGQRWEEDARQIPRPDGWAITATNKNPVETIKLFDFYFGPKGRELSNFGVPGLTYDIKNGKPVYKDTVLKAAQPVNNQMYDIGAQIPIGFWQDYEYERQWTNDVALQGIDMYIKNKYVLPQFTGVNLTVEEREIYDKYWPDVKTYMFEMGQSWVMGTKDPEKTWNDYQQQLKNRGFYQVMIVMQKAYDRQY,1.0,C4001Y3N,5.828982026905383,-0.3435841610586934
8,7std,1.8,1999,10.72,Ki=19pM,1.025595018367986,4453,20,17.803885951942867,SCYTALONE DEHYDRATASE PLUS INHIBITOR 4,GEITFSDYLGLMTCVYEWADSYDSKDWDRLRKVIAPTLRIDYRSFLDKLWEAMPAEEFVGMVSSKQVLGDPTLRTQHFIGGTRWEKVSEDEVIGYHQLRVPHQRYKDTTMKEVTMKGHAHSANLHWYKKIDGVWKFAGLKPDIRWGEFDFDRIFEDGRETFGDK,1.0,C4007STD,17.730371911316418,-0.07351404062644917
9,1fki,2.2,1994,7.0,Ki=100nM,0.6918881266383048,1806,31,20.09579608966118,"DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP 2 LIGANDS, AND THE X-RAY CRYSTAL STRUCTURES OF THEIR COMPLEXES WITH 3 FKBP12",GVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE,1.0,C4001FKI,19.98738801876546,-0.10840807089572024
10,1xk9,2.1,2005,6.85,Ki=140nM,0.6517867853726,1793,22,8.473042530443825,PSEUDOMANAS EXOTOXIN A IN COMPLEX WITH THE PJ34 INHIBITOR,EFLGDGGDVSFSTRGTQNWTVERLLQAHRQLEERGYVFVGYHGTFLEAAQSIVFGGVRARSQDLDAIWRGFYIAGDPALAYGYAQDQEPDARGRIRNGALLRVYVPRSSLPGFYRTSLTLAAPEAAGEVERLIGHPLPLRLDAITGPEEEGGRLETILGWPLAERTVVIPSAIPTDPRNVGGDLDPSSIPDKEQAISALPDYASQPGKPPREDLK,1.0,C4001XK9,8.21931292534514,-0.2537296050986857
11,1uwf,1.69,2005,6.82,Kd=0.15uM,0.791989302249303,1519,16,22.218367620687737,1.7 A RESOLUTION STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF THE FIMH 2 ADHESIN FROM UROPATHOGENIC E. COLI,FACKTANGTAIPIGGGSANVYVNLAPVVNVGQNLVVDLSTQIFCHNDYPETITDYVTLQRGSAYGGVLSNFSGTVKYSGSSYPFPTTSETPRVVYNSRTDKPWPVALYLTPVSSAGGVAIKAGSLIAVLILRQTNNYNSDDFQFVWNIYANNDVVVPT,1.0,C4001UWF,22.45892180272374,0.24055418203600354
12,1qbo,1.8,2000,7.74,Ki=18nM,0.725959732211565,1816,34,13.877891243086127,BOVINE TRYPSIN 7-[[6-[[1-(1-IMINOETHYL)PIPERIDIN-4-YL]OXY]-2-METHYL- 2 BENZIMIDAZOL-1-YL]METHYL]NAPHTHALENE-2-CARBOXIMIDAMID ZK-806711 3 INHIBITOR COMPLEX,IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN,1.0,C4001QBO,13.431528068887228,-0.4463631741988987
13,2jds,2.0,2007,8.2,Ki=6.3nM,0.8819359638995825,3302,30,8.918886488284917,STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A- 2 443654,MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVXINEKCGKEFSEF,1.0,C4002JDS,9.038682292358592,0.11979580407367507
14,2csn,2.5,1996,4.41,Ki=39uM,0.7487339485028781,5104,18,11.691472447993318,BINARY COMPLEX OF CASEIN KINASE-1 WITH CKI7,SGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL,0.9761092150170648,C4002CSN,11.917844049547488,0.22637160155417035
15,2d0k,1.9,2006,5.02,Kd=9.51uM,0.670195175388787,1410,32,8.130452902226029,METHIONINE-FREE MUTANT OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE,AISLIAALAVDRVIGNENALPWNLPADLAWFKRNTLNKPVIYGRHTWESIGRPLPGRKNIILSSQPGTDDRVTWVKSVDEAIAAAGDVPEIFVIGGGRVYEQFLPKAQKLYLTHIDAEVEGDTHFPDYEPDDWESVFSEFHDADAQNSHSYSFEILERR,1.0,C4002D0K,8.358229493196651,0.2277765909706222
16,1b1h,1.8,1998,7.03,Kd=0.093uM,0.9903405618470652,4526,31,3.6857876775585527,OLIGO-PEPTIDE BINDING PROTEIN/TRIPEPTIDE (LYS HPE LYS) 2 COMPLEX,ADVPAGVQLADKQTLVRNNGSEVQSLDPHKIEGVPESNVSRDLFEGLLISDVEGHPSPGVAEKWENKDFKVWTFHLRENAKWSDGTPVTAHDFVYSWQRLADPNTASPYASYLQYGHIANIDDIIAGKKPATDLGVKALDDHTFEVTLSEPVPYFYKLLVHPSVSPVPKSAVEKFGDKWTQPANIVTNGAYKLKNWVVNERIVLERNPQYWDNAKTVINQVTYLPISSEVTDVNRYRSGEIDMTYNNMPIELFQKLKKEIPNEVRVDPYLCTYYYEINNQKAPFNDVRVRTALKLALDRDIIVNKVKNQGDLPAYSYTPPYTDGAKLVEPEWFKWSQQKRNEEAKKLLAEAGFTADKPLTFDLLYNTSDLHKKLAIAVASIWKKNLGVNVNLENQEWKTFLDTRHQGTFDVARAGWCADYNEPTSFLNTMLSDSSNNTAHYKSPAFDKLIADTLKVADDTQRSELYAKAEQQLDKDSAIVPVYYYVNARLVKPWVGGYTGKDPLDNIYVKNLYIIKH,1.0,C4001B1H,3.5844448316119752,-0.1013428459465775
17,1ocq,1.08,2003,5.19,Ki=6.5uM,0.8216927036301246,2820,21,13.291416542104054,COMPLEX OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHEARANS AT 1.08 2 ANGSTROM RESOLUTION WITH CELLOBIO-DERIVED ISOFAGOMINE,DNDSVVEEHGQLSISNGELVNERGEQVQLKGMSSHGLQWYGQFVNYESMKWLRDDWGINVFRAAMYTSSGGYIDDPSVKEKVKEAVEAAIDLDIYVIIDWHILSDNDPNIYKEEAKDFFDEMSELYGDYPNVIYEIANEPNGSDVTWGNQIKPYAEEVIPIIRNNDPNNIIIVGTGTWSQDVHHAADNQLADPNVMYAFHFYAGTHGQNLRDQVDYALDQGAAIFVSEWGTSAATGDGGVFLDEAQVWIDFMDERNLSWANWSLTHKDESSAALMPGANPTGGWTEAELSPSGTFVREKIRES,1.0,C4001OCQ,13.157541185266773,-0.13387535683728125
18,3b68,1.9,2008,8.4,Ki=4nM,1.042534069444395,2191,31,8.313342468129184,CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING 2 DOMAIN IN COMPLEX WITH SARM S-4,PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ,1.0,C4003B68,8.179234289146455,-0.13410817898272853
19,1b05,2.0,1998,7.12,Kd=75nM,0.9780281508680388,4369,25,3.075113266192252,STRUCTURE OF OLIGO-PEPTIDE BINDING PROTEIN COMPLEXED WITH 2 LYS-CYS-LYS,ADVPAGVQLADKQTLVRNNGSEVQSLDPHKIEGVPESNVSRDLFEGLLISDVEGHPSPGVAEKWENKDFKVWTFHLRENAKWSDGTPVTAHDFVYSWQRLADPNTASPYASYLQYGHIANIDDIIAGKKPATDLGVKALDDHTFEVTLSEPVPYFYKLLVHPSVSPVPKSAVEKFGDKWTQPANIVTNGAYKLKNWVVNERIVLERNPQYWDNAKTVINQVTYLPISSEVTDVNRYRSGEIDMTYNNMPIELFQKLKKEIPNEVRVDPYLCTYYYEINNQKAPFNDVRVRTALKLALDRDIIVNKVKNQGDLPAYSYTPPYTDGAKLVEPEWFKWSQQKRNEEAKKLLAEAGFTADKPLTFDLLYNTSDLHKKLAIAVASIWKKNLGVNVNLENQEWKTFLDTRHQGTFDVARAGWCADYNEPTSFLNTMLSDSSNNTAHYKSPAFDKLIADTLKVADDTQRSELYAKAEQQLDKDSAIVPVYYYVNARLVKPWVGGYTGKDPLDNIYVKNLYIIKH,1.0,C4001B05,2.932028042128513,-0.1430852240637388
20,1o5a,1.68,2004,6.42,Ki=0.38uM,0.7692210048102619,2134,25,10.229322417892192,DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 2 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA),KPSSPPEELKFQCGQKTLRPRFK,1.0,C4001O5A,10.22963891513334,0.00031649724114757305
21,3bgq,2.0,2007,7.96,Ki=11nM,0.7935794780912684,2359,26,11.038514797827553,HUMAN PIM-1 KINASE IN COMPLEX WITH AN TRIAZOLO PYRIDAZINE 2 INHIBITOR VX2,MGSSHHHHHHSSGLVPRGSHMLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK,1.0,C4003BGQ,12.127175363574688,1.0886605657471353
22,1eld,2.0,1995,6.7,Ki=0.20uM,0.6948133720791486,1989,33,13.022031319691544,STRUCTURAL ANALYSIS OF THE ACTIVE SITE OF PORCINE PANCREATIC ELASTASE 2 BASED ON THE X-RAY CRYSTAL STRUCTURES OF COMPLEXES WITH 3 TRIFLUOROACETYL-DIPEPTIDE-ANILIDE INHIBITORS,VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVVVGEHNLNQNNGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAGGDGVRSGCQGDSGGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINNVIASN,1.0,C4001ELD,13.107546291560752,0.0855149718692072
23,3b67,1.9,2008,8.85,Ki=1.4nM,1.019740456689478,2225,32,8.30780914318143,CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING 2 DOMAIN IN COMPLEX WITH SARM C-23,PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ,1.0,C4003B67,8.44333722266369,0.13552807948225976
24,1y6q,2.2,2005,11.7,Ki=2pM,1.0455643140530382,3674,20,15.581791735636465,CYRSTAL STRUCTURE OF MTA/ADOHCY NUCLEOSIDASE COMPLEXED WITH 2 MT-DADME-IMMA,FQGAMDPEFSMKIGIIGAMEEEVTLLRDKIENRQTISLGGCEIYTGQLNGTEVALLKSGIGKVAAALGATLLLEHCKPDVIINTGSAGGLAPTLKVGDIVVSDEARYHDADVTAFGYEYGQLPGCPAGFKADDKLIAAAEACIAELNLNAVRGLIVSGDAFINGSVGLAKIRHNFPQAIAVEMEATAIAHVCHNFNVPFVVVRAISDVADQQSHLSFDEFLAVAAKQSSLMVESLVQKLAHG,1.0,C4001Y6Q,15.384277748077093,-0.19751398755937188
25,1hms,1.4,1995,6.37,Kd=0.43uM,0.7412284302621752,1273,20,7.002731164769845,1.4 ANGSTROMS STRUCTURAL STUDIES ON HUMAN MUSCLE FATTY ACID BINDING 2 PROTEIN: BINDING INTERACTIONS WITH THREE SATURATED AND UNSATURATED 3 C18 FATTY ACIDS,VDAFLGTWKLVDSKNFDDYMKSLGVGFATRQVASMTKPTTIIEKNGDILTLKTHSTFKNTEISFKLGVEFDETTADDRKVKSIVTLDGGKLVHLQKWDGQETTLVRELIDGKLILTLTHGTAVCTRTYEKEA,1.0,C4001HMS,6.284337974179356,-0.718393190590489
26,2gv6,2.1,2006,7.34,Ki=46nM,0.5502253533452939,2146,39,13.756219253692755,CRYSTAL STRUCTURE OF MATRIPTASE WITH INHIBITOR CJ-730,VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTGV,1.0,C4002GV6,13.802915094952692,0.04669584125993609
27,1dhi,1.9,1994,7.26,Kd=55nM,0.691543470790378,2917,33,10.244624208349856,LONG-RANGE STRUCTURAL EFFECTS IN A SECOND-SITE REVERTANT OF A MUTANT 2 DIHYDROFOLATE REDUCTASE,MISLIAALAVDRVIGMENAMPWNLPASLAWFKRNTLDKPVIMGRHTWESIGRPLPGRKNIILSSQPGTDDRVTWVKSVDEAIAACGDVPEIMVIGGGRVYEQFLPKAQKLYLTHIDAEVEGDTHFPDYEPDDWESVFSEFHDADAQNSHSYCFEILERR,1.0,C4001DHI,10.277627932902703,0.03300372455284695
28,1erb,1.9,1994,8.1,Kd=8nM,0.929641602780923,1585,24,9.153362234413596,THE INTERACTION OF N-ETHYL RETINAMIDE WITH PLASMA RETINOL-BINDING 2 PROTEIN (RBP) AND THE CRYSTAL STRUCTURE OF THE RETINOID-RBP COMPLEX 3 AT 1.9 ANGSTROMS RESOLUTION,ERDCRVSSFRVKENFDKARFAGTWYAMAKKDPEGLFLQDNIVAEFSVDENGHMSATAKGRVRLLNNWDVCADMVGTFTDTEDPAKFKMKYWGVASFLQKGNDDHWIIDTDYETFAVQYSCRLLNLDGTCADSYSFVFARDPSGFSPEVQKIVRQRQEELCLARQYRLIPHNGYCDGKSERNIL,0.9941520467836256,C4001ERB,17.251165644411508,8.097803409997912
29,2f80,1.45,2006,8.18,Ki=6.6nM,0.9405569136271752,1749,38,5.019715086156805,HIV-1 PROTEASE MUTANT D30N COMPLEXED WITH INHIBITOR TMC114,PQITLWKRPLVTIKIGGQLKEALLDTGADNTVIEEMSLPGRWKPKMIGGIGGFIKVRQYDQIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF,1.0,C4002F80,5.219714741976369,0.19999965581956403
30,1fh9,1.72,2000,6.43,Ki=0.37uM,0.8520987245834346,2690,20,8.726555075963724,CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE-DERIVED LACTAM 2 OXIME INHIBITOR,ATTLKEAADGAGRDFGFALDPNRLSEAQYKAIADSEFNLVVAENAMKWDATEPSQNSFSFGAGDRVASYAADTGKELYGHTLVWHSQLPDWAKNLNGSAFESAMVNHVTKVADHFEGKVASWDVVNEAFADGGGRRQDSAFQQKLGNGYIETAFRAARAADPTAKLCINDYNVEGINAKSNSLYDLVKDFKARGVPLDCVGFQSHLIVGQVPGDFRQNLQRFADLGVDVRITELDIRMRTPSDATKLATQAADYKKVVQACMQVTRCQGVTVWGITDKYSWVPDVFPGEGAALVWDASYAKKPAYAAVMEAF,1.0,C4001FH9,8.734687225510156,0.008132149546431933
31,1fcy,1.3,2000,8.52,Kd=3nM,1.031290434124131,2192,29,8.505449925800143,ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: 2 THE COMPLEX WITH THE RARBETA/GAMMA-SELECTIVE RETINOID CD564,ASPQLEELITKVSKAHQETFPSLCQLGKYTTNSSADHRVQLDLGLWDKFSELATKCIIKIVEFAKRLPGFTGLSIADQITLLKAACLDILMLRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFAGQLLPLEMDDTETGLLSAICLICGDRMDLEEPEKVDKLQEPLLEALRLYARRRRPSQPYMFPRMLMKITDLRGISTKGAERAITLKMEIPGPMPPLIREMLE,1.0,C4001FCY,8.941373643156071,0.4359237173559283
32,1ela,2.0,1994,6.36,Ki=0.44uM,0.6126117159842361,2021,32,13.103090952527054,ANALOGOUS INHIBITORS OF ELASTASE DO NOT ALWAYS BIND ANALOGOUSLY,VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVVVGEHNLNQNNGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAGGDGVRSGCQGDSGGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINNVIASN,1.0,C4001ELA,13.067666600623571,-0.03542435190348314
33,1f4e,1.9,2000,2.96,Ki=1.1mM,0.7350544096552406,4736,18,18.68505909721074,CRYSTAL STRUCTURE OF E. COLI THYMIDYLATE SYNTHASE COMPLEXED WITH 2 TOSYL-D-PROLINE,XKQYLELMQKVLDEGTQKNDRTGTGTLSIFGHQMRFNLQDGFPLVTTKRCHLRSIIHELLWFLQGDTNIAYLHENNVTIWDEWADENGDLGPVYGKQWRAWPTPDGRHIDQITTVLNQLKNDPDSRRIIVSAWNVGELDKMALAPCHAFFQFYVADGKLSCQLYQRSCDVFLGLPFNIASYALLVHMMAQQCDLEVGDFVWTGGDTHLYSNHMDQTHLQLSREPRPLPKLIIKRKPESIFDYRFEDFEIEGYDPHPGIKAPVAI,0.9581749049429658,C4001F4E,18.98857655055448,0.3035174533437406
34,1jet,1.2,1997,7.25,Kd=56nM,0.9906286919125152,4757,24,2.9774802653094,OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KAK,ADVPAGVQLADKQTLVRNNGSEVQSLDPHKIEGVPESNVSRDLFEGLLISDVEGHPSPGVAEKWENKDFKVWTFHLRENAKWSDGTPVTAHDFVYSWQRLADPNTASPYASYLQYGHIANIDDIIAGKKPATDLGVKALDDHTFEVTLSEPVPYFYKLLVHPSVSPVPKSAVEKFGDKWTQPANIVTNGAYKLKNWVVNERIVLERNPQYWDNAKTVINQVTYLPISSEVTDVNRYRSGEIDMTYNNMPIELFQKLKKEIPNEVRVDPYLCTYYYEINNQKAPFNDVRVRTALKLALDRDIIVNKVKNQGDLPAYSYTPPYTDGAKLVEPEWFKWSQQKRNEEAKKLLAEAGFTADKPLTFDLLYNTSDLHKKLAIAVASIWKKNLGVNVNLENQEWKTFLDTRHQGTFDVARAGWCADYNEPTSFLNTMLSDSSNNTAHYKSPAFDKLIADTLKVADDTQRSELYAKAEQQLDKDSAIVPVYYYVNARLVKPWVGGYTGKDPLDNIYVKNLYIIKH,1.0,C4001JET,2.966509123267311,-0.010971142042089266
35,2drc,1.9,1994,9.89,Kd=0.13nM,0.7288516961976559,2584,33,10.162734676800738,INVESTIGATION OF THE FUNCTIONAL ROLE OF TRYPTOPHAN-22 IN ESCHERICHIA 2 COLI DIHYDROFOLATE REDUCTASE BY SITE-DIRECTED MUTAGENESIS,MISLIAALAVDRVIGMENAMPFNLPADLAWFKRNTLDKPVIMGRHTWESIGRPLPGRKNIILSSQPGTDDRVTWVKSVDEAIAACGDVPEIMVIGGGRVYEQFLPKAQKLYLTHIDAEVEGDTHFPDYEPDDWESVFSEFHDADAQNSHSYCFEILERR,1.0,C4002DRC,10.486739722765334,0.32400504596459534
36,1hmr,1.4,1995,6.55,Kd=0.28uM,0.7549712711322125,1271,20,6.839213997053282,1.4 ANGSTROMS STRUCTURAL STUDIES ON HUMAN MUSCLE FATTY ACID BINDING 2 PROTEIN: BINDING INTERACTIONS WITH THREE SATURATED AND UNSATURATED 3 C18 FATTY ACIDS,VDAFLGTWKLVDSKNFDDYMKSLGVGFATRQVASMTKPTTIIEKNGDILTLKTHSTFKNTEISFKLGVEFDETTADDRKVKSIVTLDGGKLVHLQKWDGQETTLVRELIDGKLILTLTHGTAVCTRTYEKEA,1.0,C4001HMR,7.140124366899796,0.3009103698465143
37,3gst,1.9,1993,6.72,Ki=0.19uM,0.8065652736536669,4108,35,11.811041182969923,"STRUCTURE OF THE XENOBIOTIC SUBSTRATE BINDING SITE OF A GLUTATHIONE S- 2 TRANSFERASE AS REVEALED BY X-RAY CRYSTALLOGRAPHIC ANALYSIS OF PRODUC 3 COMPLEXES WITH THE DIASTEREOMERS OF 9-(S-GLUTATHIONYL)-10-HYDROXY-9, 4 10-DIHYDROPHENANTHRENE",PMILGYWNVRGLTHPIRLLLEYTDSSYEEKRYAMGDAPDYDRSQWLNEKFKLGLDFPNLPYLIDGSRKITQSNAIMRYLARKHHLCGETEEERIRADIVENQVMDNRMQLIMLCYNPDFEKQKPEFLKTIPEKMKLYSEFLGKRPWFAGDKVTYVDFLAYDILDQYHIFEPKCLDAFPNLKDFLARFEGLKKISAYMKSSRYLSTPIFSKLAQWSNK,1.0,C4003GST,11.80023764645128,-0.010803536518643853
38,1lbk,1.86,2002,3.18,Kd=668uM,0.7605191433087121,3742,20,13.727024906472176,"CRYSTAL STRUCTURE OF A RECOMBINANT GLUTATHIONE TRANSFERASE, CREATED BY 2 REPLACING THE LAST SEVEN RESIDUES OF EACH SUBUNIT OF THE HUMAN CLASS 3 PI ISOENZYME WITH THE ADDITIONAL C-TERMINAL HELIX OF HUMAN CLASS 4 ALPHA ISOENZYME",PPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPMDEKSL,1.0,C4001LBK,12.237863144509236,-1.48916176196294
39,1pzi,1.99,2004,4.22,Kd=60uM,0.6590907603181357,4718,23,27.289716741878127,HEAT-LABILE ENTEROTOXIN B-PENTAMER COMPLEXED WITH NITROPHENYL 2 GALACTOSIDE 2A,APQTITELCSEYRNTQIYTINDKILSYTESMAGKREMVIITFKSGETFQVEVPGSQHIDSQKKAIERMKDTLRITYLTETKIDKLCVWNNKTPNSIAAISMKN,1.0,C4001PZI,27.315554363187346,0.025837621309218406
40,3bgb,1.9,2008,6.05,Ki=0.9uM,0.937242923143752,1662,35,5.429304091840052,HIV-1 PROTEASE IN COMPLEX WITH A ISOBUTYL DECORATED 2 OLIGOAMINE,PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF,1.0,C4003BGB,5.360603260235999,-0.06870083160405294
41,5er1,2.0,1991,6.02,Ki=960nM,0.6848582716364389,2754,37,10.922263603710013,A RATIONAL APPROACH TO THE DESIGN OF ANTIHYPERTENSIVES. X-RAY STUDIES 2 OF COMPLEXES BETWEEN ASPARTIC PROTEINASES AND AMINOALCOHOL RENIN 3 INHIBITORS,STGSATTTPIDSLDDAYITPVQIGTPAQTLNLDFDTGSSDLWVFSSETTASEVDGQTIYTPSKSTTAKLLSGATWSISYGDGSSSSGDVYTDTVSVGGLTVTGQAVESAKKVSSSFTEDSTIDGLLGLAFSTLNTVSPTQQKTFFDNAKASLDSPVFTADLGYHAPGTYNFGFIDTTAYTGSITYTAVSTKQGFWEWTSTGYAVGSGTFKSTSIDGIADTGTTLLYLPATVVSAYWAQVSGAKSSSSVGGYVFPCSATLPSFTFGVGSARIVIPGDYIDFGPISTGSSSCFGGIQSSAGIGINIFGDVALKAAFVVFNGATTPTLGFASK,1.0,C4005ER1,10.659906062334056,-0.2623575413759571
42,3bex,1.51,2008,5.57,Kd=2.7uM,0.9612095713225046,4458,15,15.522907884281068,TYPE III PANTOTHENATE KINASE FROM THERMOTOGA MARITIMA 2 COMPLEXED WITH PANTOTHENATE REVDAT   2   01-JUL-08 3BEX    1       TITLE,MDPMYLLVDVGNTHSVFSITEDGKTFRRWRLSTGVFQTEDELFSHLHPLLGDAMREIKGIGVASVVPTQNTVIERFSQKYFHISPIWVKAKNGCVKWNVKNPSEVGADRVANVVAFVKEYGKNGIIIDMGTATTVDLVVNGSYEGGAILPGFFMMVHSLFRGTAKLPLVEVKPADFVVGKDTEENIRLGVVNGSVYALEGIIGRIKEVYGDLPVVLTGGQSKIVKDMIKHEIFDEDLTIKGVYHFCFGD,1.0,C4003BEX,15.445809351270771,-0.07709853301029668
43,1ogz,2.3,2003,5.85,Kd=1.4uM,0.7857967598574451,2094,20,15.399712418172708,CRYSTAL STRUCTURE OF 5-3-KETOSTEROID ISOMERASE MUTANTS P39A 2 COMPLEXED WITH EQUILENIN FROM PSEUDOMONAS TESTOSTERONI,MNTPEHMTAVVQRYVAALNAGDLDGIVALFADDATVEDAVGSEPRSGTAAIREFYANSLKLPLAVELTQEVRAVANEAAFAFIVSFEYQGRKTVVAPIDHFRFNGAGKVVSMRALFGEKNIHAGA,0.976,C4001OGZ,15.990222491734462,0.5905100735617541
44,1owh,1.61,2003,7.4,Ki=40nM,0.7271056448014279,2128,24,11.095852539905255,SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE,IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT,1.0,C4001OWH,10.753141625303348,-0.3427109146019074
45,1ugx,1.6,2003,5.91,Kd=1.24uM,0.5309814025957778,5079,27,34.33404570570669,CRYSTAL STRUCTURE OF JACALIN- ME-ALPHA-T-ANTIGEN (GAL-BETA(1-3)- 2 GALNAC-ALPHA-O-ME) COMPLEX,GKAFDDGAFTGIREINLSYNKETAIGDFQVVYDLNGSPYVGQNHVSFITGFTPVKISLDFPSEYIMEVSGYTGNVSGYVVVRSLTFKTNKKTYGPYGVTSGTPFNLPIENGLIVGFKGSIGYWLDYFSMYLSL,0.9932432432432432,C4001UGX,34.51274170570947,0.1786960000027804
46,2oxx,2.3,2007,6.7,Ki=0.20uM,0.7715578597344734,2846,14,14.522203685424834,"PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE 2 DERIVATIVES K17, K22 AND K32",MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVRAAENSRTRA,1.0,C4002OXX,14.233121179131624,-0.28908250629321053
47,3djk,1.0,2008,10.59,Ki=26pM,0.9467173572867408,1762,38,5.023030370149536,WILD TYPE HIV-1 PROTEASE WITH POTENT ANTIVIRAL INHIBITOR GRL-0255A,PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYDQIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF,1.0,C4003DJK,5.255197808676359,0.23216743852682242
48,1v2r,1.7,2004,3.55,Ki=278.96uM,0.5208107528242679,1747,30,14.835014976894067,TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSRI)BT.B4,IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSRIITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN,1.0,C4001V2R,19.7260019924969,4.890987015602834
49,1g74,1.7,2003,6.52,Kd=0.30uM,0.8449829546235583,1155,20,6.147754389049704,"TOWARD CHANGING SPECIFICITY: ADIPOCYTE LIPID BINDING PROTEIN MUTANT, 2 OLEIC ACID BOUND FORM",CDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDLVTIRSESTFKNTEISFKLGVEFDEETVDGRKVKSIITLDGGALVQVQKWDGKSTTIKRKRDGDKLVVECVMKGVTSTRVYERA,1.0,C4001G74,5.5296738929982485,-0.6180804960514559
50,2f35,1.87,2006,5.4,Kd=3.94uM,0.7368504993453868,2235,24,4.8589452240560735,CRYSTAL STRUCTURE OF THE GLUR5 LIGAND BINDING CORE WITH UBP302 AT 1.87 2 ANGSTROMS RESOLUTION,GSNRTLIVTTILEEPYVMYRKSDKPLYGNDRFEGYCLDLLKELSNILGFLYDVKLVPDGKYGAQNDKGEWNGMVKELIDHRADLAVAPLTITYVREKVIDFSKPFMTLGISILYRKGTPIDSADDLAKQTKIEYGAVRDGSTMTFFKKSKISTYEKMWAFMSSRQQSALVKNSDEGIQRVLTTDYALLMESTSIEYVTQRNCNLTQIGGLIDSKGYGVGTPIGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNGCPS,1.0,C4002F35,5.027647869760662,0.16870264570458815
51,2ogy,2.3,2007,4.48,Kd=33.2uM,0.6510097516273059,4345,33,21.2330475705231,ASN199ALA MUTANT OF THE 5-METHYLTETRAHYDROFOLATE CORRINOID/IRON SULFUR 2 PROTEIN METHYLTRANSFERASE COMPLEXED WITH METHYLTETRAHYDROFOLATE TO 3 2.3 ANGSTROM RESOLUTION,MLIIGERINGMFGDIKRAIQERDPAPVQEWARRQEEGGARALDLNVGPAVQDKVSAMEWLVEVTQEVSNLTLCLDSTNIKAIEAGLKKCKNRAMINSTNAEREKVEKLFPLAVEHGAALIGLTMNKTGIPKDSDTRLAFAMELVAAADEFGLPMEDLYIDPLILPANVAQDHAPEVLKTLQQIKMLADPAPKTVLGLSAVSQNCQNRPLINRTFLAMAMACGLDAAIADACDEALIETAATAEILLNQTVYCDSFVKMFKTR,1.0,C4002OGY,22.36204949505622,1.1290019245331173
52,2v00,1.55,2007,3.66,Kd=0.22mM,0.7858785532742243,2994,16,7.3416202826781,X-RAY CRYSTAL STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH 2 COMPOUND 1,STGSATTTPIDSLDDAYITPVQIGTPAQTLNLDFDTGSSDLWVFSSETTASEVDGQTIYTPSKSTTAKLLSGATWSISYGDGSSSSGDVYTDTVSVGGLTVTGQAVESAKKVSSSFTEDSTIDGLLGLAFSTLNTVSPTQQKTFFDNAKASLDSPVFTADLGYHAPGTYNFGFIDTTAYTGSITYTAVSTKQGFWEWTSTGYAVGSGTFKSTSIDGIADTGTTLLYLPATVVSAYWAQVSGAKSSSSVGGYVFPCSATLPSFTFGVGSARIVIPGDYIDFGPISTGSSSCFGGIQSSAGIGINIFGDVALKAAFVVFNGATTPTLGFASK,1.0,C4002V00,7.794938086548636,0.45331780387053566
53,1kdk,1.7,2002,9.05,Kd=0.9nM,1.0246935981660443,2953,21,15.34421979322302,THE STRUCTURE OF THE N-TERMINAL LG DOMAIN OF SHBG IN 2 CRYSTALS SOAKED WITH EDTA,DPPAVHLSNGPGQEPIAVMTFDLTKITKTSSSFEVRTWDPEGVIFYGDTNPKDDWFMLGLRDGRPEIQLHNHWAQLTVGAGPRLDDGRWHQVEVKMEGDSVLLEVDGEEVLRLRQVSGPLTSKRHPIMRIALGGLLFPASNLRLPLVPALDGCLRRDSWLDKQAEISASAPTSLRSC,0.9717514124293786,C4001KDK,15.089192592510742,-0.2550272007122789
54,1c5x,1.75,2000,6.68,Ki=0.21uM,0.8769761684463228,2316,13,12.316318414843028,"STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- 2 MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR",KPSSPPEELKFQCGQKTLRPRFK,1.0,C4001C5X,12.676101702392716,0.35978328754968736
55,1w3k,1.2,2004,4.3,Ki=50uM,0.8177733445633892,2858,21,13.133241809760143,ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS IN COMPLEX WITH 2 CELLOBIO DERIVED-TETRAHYDROOXAZINE,DNDSVVEEHGQLSISNGELVNERGEQVQLKGMSSHGLQWYGQFVNYESMKWLRDDWGINVFRAAMYTSSGGYIDDPSVKEKVKEAVEAAIDLDIYVIIDWHILSDNDPNIYKEEAKDFFDEMSELYGDYPNVIYEIANEPNGSDVTWGNQIKPYAEEVIPIIRNNDPNNIIIVGTGTWSQDVHHAADNQLADPNVMYAFHFYAGTHGQNLRDQVDYALDQGAAIFVSEWGTSAATGDGGVFLDEAQVWIDFMDERNLSWANWSLTHKDESSAALMPGANPTGGWTEAELSPSGTFVREKIRES,1.0,C4001W3K,13.09800175971528,-0.03524005004486419
56,1n4h,2.1,2003,6.55,Ki=0.28uM,0.8822133381992712,2111,22,7.119181769600778,CHARACTERIZATION OF LIGANDS FOR THE ORPHAN NUCLEAR RECEPTOR 2 RORBETA,GQLAPGITMSEIDRIAQNIIKSHLETCQYTMEELHQLAWQTHTYEEIKAYQSKSREALWQQCAIQITHAIQYVVEFAKRITGFMELCQNDQILLLKSGCLEVVLVRMCRAFNPLNNTVLFEGKYGGMQMFKALGSDDLVNEAFDFAKNLCSLQLTEEEIALFSSAVLISPDRAWLLEPRKVQKLQEKIYFALQHVIQKNHLDDETLAKLIAKIPTITAVCNLHGEKLQVFKQSHPDIVNTLFPPLYKELFNPDCAAVCK,1.0,C4001N4H,7.180180823260751,0.06099905365997316
57,2e2r,1.6,2007,8.26,Kd=5.5nM,1.0709277719147634,4402,17,17.513991143586374,CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR GAMMA LIGAND 2 BINDING DOMAIN COMPLEX WITH BISPHENOL A,LGSPEFLNPQLVQPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKVC,0.873015873015873,C4002E2R,17.161532665127694,-0.3524584784586793
58,1lf2,1.8,2002,7.52,Ki=30nM,0.7812830637914904,2981,39,8.186309479126413,CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM IN COMPLEX WITH 2 INHIBITOR RS370,LGSSNDNIELVDFQNIMFYGDAEVGDNQQPFTFILDTGSANLWVPSVKCTTAGCLTKHLYDSSKSRTYEKDGTKVEMNYVSGTVSGFFSKDLVTVGNLSLPYKFIEVIDTNGFEPTYTASTFDGILGLGWKDLSIGSVDPIVVELKNQNKIENALFTFYLPVHDKHTGFLTIGGIEERFYEGPLTYEKLNHDLYWQITLDAHVGNISLEKANCIVDSGTSAITVPTDFLNKMLQNLDVIKVPFLPFYVTLCNNSKLPTFEFTSENGKYTLEPEYYLQHIEDVGPGLCMLNIIGLDFPVPTFILGDPFMRKYFTVFDYDNHSVGIALAKKNL,1.0,C4001LF2,8.238502021676574,0.052192542550161036
59,5std,1.95,1999,10.49,Ki=32pM,1.0237183666860672,4374,28,17.151004280319835,SCYTALONE DEHYDRATASE PLUS INHIBITOR 2,GEITFSDYLGLMTCVYEWADSYDSKDWDRLRKVIAPTLRIDYRSFLDKLWEAMPAEEFVGMVSSKQVLGDPTLRTQHFIGGTRWEKVSEDEVIGYHQLRVPHQRYKDTTMKEVTMKGHAHSANLHWYKKIDGVWKFAGLKPDIRWGEFDFDRIFEDGRETFGDK,1.0,C4005STD,17.643488356224463,0.4924840759046276
60,1v0k,1.03,2004,5.1,Ki=8uM,0.8355816187769228,3049,18,9.774988234460574,XYLANASE XYN10A FROM STREPTOMYCES LIVIDANS IN COMPLEX WITH XYLOBIO- 2 DEOXYNOJIRIMYCIN AT PH 5.8,AESTLGAAAAQSGRYFGTAIASGRLSDSTYTSIAGREFNMVTAENEMKIDATEPQRGQFNFSSADRVYNWAVQNGKQVRGHTLAWHSQQPGWMQSLSGSALRQAMIDHINGVMAHYKGKIVQWDVVNEAFADGSSGARRDSNLQRSGNDWIEVAFRTARAADPSAKLCYNDYNVENWTWAKTQAMYNMVRDFKQRGVPIDCVGFQSHFNSGSPYNSNFRTTLQNFAALGVDVAITELDIQGAPASTYANVTNDCLAVSRCLGITVWGVRDSDSWRSEQTPLLFNNDGSKKAAYTAVLDALNGGDSSEPPADGG,0.9966329966329966,C4001V0K,9.710859908757907,-0.0641283257026668
61,1fh7,1.82,2000,5.24,Ki=5.8uM,0.848931493640012,2686,18,8.939191859214757,CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE-DERIVED INHIBITOR 2 DEOXYNOJIRIMYCIN,ATTLKEAADGAGRDFGFALDPNRLSEAQYKAIADSEFNLVVAENAMKWDATEPSQNSFSFGAGDRVASYAADTGKELYGHTLVWHSQLPDWAKNLNGSAFESAMVNHVTKVADHFEGKVASWDVVNEAFADGGGRRQDSAFQQKLGNGYIETAFRAARAADPTAKLCINDYNVEGINAKSNSLYDLVKDFKARGVPLDCVGFQSHLIVGQVPGDFRQNLQRFADLGVDVRITELDIRMRTPSDATKLATQAADYKKVVQACMQVTRCQGVTVWGITDKYSWVPDVFPGEGAALVWDASYAKKPAYAAVMEAF,1.0,C4001FH7,8.992120751663759,0.05292889244900145
62,1v0l,0.98,2004,7.55,Ki=0.028uM,0.8295329581282965,2989,17,10.006162704292976,XYLANASE XYN10A FROM STREPTOMYCES LIVIDANS IN COMPLEX WITH XYLOBIO- 2 ISOFAGOMINE AT PH 5.8,AESTLGAAAAQSGRYFGTAIASGRLSDSTYTSIAGREFNMVTAENEMKIDATEPQRGQFNFSSADRVYNWAVQNGKQVRGHTLAWHSQQPGWMQSLSGSALRQAMIDHINGVMAHYKGKIVQWDVVNEAFADGSSGARRDSNLQRSGNDWIEVAFRTARAADPSAKLCYNDYNVENWTWAKTQAMYNMVRDFKQRGVPIDCVGFQSHFNSGSPYNSNFRTTLQNFAALGVDVAITELDIQGAPASTYANVTNDCLAVSRCLGITVWGVRDSDSWRSEQTPLLFNNDGSKKAAYTAVLDALNGGDSSEPPADGG,1.0,C4001V0L,9.87704070028828,-0.12912200400469587
63,2j34,2.01,2006,7.82,Ki=15nM,0.7753677055386475,2462,30,16.664702681341907,CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX,IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK,1.0,C4002J34,16.492772319001446,-0.17193036234046133
64,1mfi,1.8,1999,5.59,Ki=2.6uM,1.0351618926939878,2713,13,15.289282929738157,CRYSTAL STRUCTURE OF MACROPHAGE MIGRATION INHIBITORY FACTOR COMPLEXED 2 WITH (E)-2-FLUORO-P-HYDROXYCINNAMATE,PMFIVNTNVPRASVPEGFLSELTQQLAQATGKPAQYIAVHVVPDQLMTFSGTNDPCALCSLHSIGKIGGAQNRNYSKLLCGLLSDRLHISPDRVYINYYDMNAANVGWNGSTFA,1.0,C4001MFI,15.455160367495854,0.1658774377576968
65,2gst,1.8,1993,6.07,Ki=0.85uM,0.8028139976303178,4141,35,12.44334538267453,"STRUCTURE OF THE XENOBIOTIC SUBSTRATE BINDING SITE OF A GLUTATHIONE S- 2 TRANSFERASE AS REVEALED BY X-RAY CRYSTALLOGRAPHIC ANALYSIS OF PRODUC 3 COMPLEXES WITH THE DIASTEREOMERS OF 9-(S-GLUTATHIONYL)-10-HYDROXY-9, 4 10-DIHYDROPHENANTHRENE",PMILGYWNVRGLTHPIRLLLEYTDSSYEEKRYAMGDAPDYDRSQWLNEKFKLGLDFPNLPYLIDGSRKITQSNAIMRYLARKHHLCGETEEERIRADIVENQVMDNRMQLIMLCYNPDFEKQKPEFLKTIPEKMKLYSEFLGKRPWFAGDKVTYVDFLAYDILDQYHIFEPKCLDAFPNLKDFLARFEGLKKISAYMKSSRYLSTPIFSKLAQWSNK,1.0,C4002GST,12.245570236301772,-0.1977751463727575
66,2fqw,1.71,2006,6.68,Kd=210nM,0.9872956662815564,2592,19,5.563682947272199,PNRA FROM TREPONEMA PALLIDUM AS PURIFIED FROM E. COLI 2 (BOUND TO INOSINE),EGGDFVVGMVTDSGDIDDKSFNQQVWEGISRFAQENNAKCKYVTASTDAEYVPSLSAFADENMGLVVACGSFLVEAVIETSARFPKQKFLVIDAVVQDRDNVVSAVFGQNEGSFLVGVAAALKAKEAGKSAVGFIVGMELGMMPLFEAGFEAGVKAVDPDIQVVVEVANTFSDPQKGQALAAKLYDSGVNVIFQVAGGTGNGVIKEARDRRLNGQDVWVIGVDRDQYMDGVYDGSKSVVLTSMVKRADVAAERISKMAYDGSFPGGQSIMFGLEDKAVGIPEENPNLSSAVMEKIRSFEEKIVSKEIVVPVRSARMMN,1.0,C4002FQW,5.285589260135857,-0.27809368713634264
67,2f34,1.74,2006,6.89,Kd=0.13uM,0.7861045210011026,2269,24,4.889541979967209,CRYSTAL STRUCTURE OF THE GLUR5 LIGAND BINDING CORE DIMER WITH UBP310 2 AT 1.74 ANGSTROMS RESOLUTION,GSNRTLIVTTILEEPYVMYRKSDKPLYGNDRFEGYCLDLLKELSNILGFLYDVKLVPDGKYGAQNDKGEWNGMVKELIDHRADLAVAPLTITYVREKVIDFSKPFMTLGISILYRKGTPIDSADDLAKQTKIEYGAVRDGSTMTFFKKSKISTYEKMWAFMSSRQQSALVKNSDEGIQRVLTTDYALLMESTSIEYVTQRNCNLTQIGGLIDSKGYGVGTPIGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNGCPS,0.999347421472719,C4002F34,5.080660793049948,0.19111881308273926
68,2qm9,2.31,2007,7.77,Kd=17nM,0.9009753492597412,2215,31,12.906755990882992,TROGLITAZONE BOUND TO FATTY ACID BINDING PROTEIN 4,GSHMASMTGGNNMGRGSSSKVYKMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDLVTIRSESTFKNTEISFKLGVEFDEITADDRKVKSIITLDGGALVQVQKWDGKSTTIKRKRDGDKLVVECVMKGVTSTRVYERA,1.0,C4002QM9,13.073609128726853,0.16685313784386047
69,2cgf,2.2,2006,6.41,Kd=0.39uM,0.831431766556002,3778,23,20.60357340788389,A RADICICOL ANALOGUE BOUND TO THE ATP BINDING SITE OF THE N- 2 TERMINAL DOMAIN OF THE YEAST HSP90 CHAPERONE,MRGSHHHHHHGMASETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLETEPDLFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSGTKAFMEALSAGADVSMIGQFGVGFYSLFLVADRVQVISKSNDDEQYIWESNAGGSFTVTLDEVNERIGRGTILRLFLKDDQLEYLEEKRIKEVIKKHSEFVAYPIQLVVTKEVE,0.985981308411215,C4002CGF,21.592474428823184,0.988901020939295
70,2hb1,2.0,2006,3.8,Ki=160uM,0.9421710315468668,2611,14,12.7179725277871,CRYSTAL STRUCTURE OF PTP1B WITH MONOCYCLIC THIOPHENE INHIBITOR,MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDL,1.0,C4002HB1,12.790469915365252,0.07249738757815116
71,2iwx,1.5,2006,6.68,Kd=0.21uM,0.8098364974746167,2124,24,6.975814950572743,ANALOGUES OF RADICICOL BOUND TO THE ATP-BINDING SITE OF 2 HSP90.,MASETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLETEPDLFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSGTKAFMEALSAGADVSMIGQFGVGFYSLFLVADRVQVISKSNDDEQYIWESNAGGSFTVTLDEVNERIGRGTILRLFLKDDQLEYLEEKRIKEVIKRHSEFVAYPIQLVVTKEVE,1.0,C4002IWX,7.268429813382942,0.2926148628101988
72,1q8t,2.0,2003,4.76,Kd=17.5uM,0.8257076955336549,3218,18,9.328285388711612,THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE 2 (PKA) IN COMPLEX WITH RHO-KINASE INHIBITOR Y-27632,GNAAAAKKGXEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVXINEKCGKEFSEF,1.0,C4001Q8T,9.658847259588557,0.3305618708769451
73,3eko,1.55,2008,6.7,Ki=0.2uM,0.8360356706117065,1903,16,6.598916304545638,DIHYDROXYLPHENYL AMIDES AS INHIBITORS OF THE HSP90 2 MOLECULAR CHAPERONE,MDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKELEHHHHHH,1.0,C4003EKO,6.877003918748302,0.27808761420266404
74,1adl,1.6,1994,5.36,Kd=4.4uM,0.7351629493671106,2236,22,14.642828669303595,ADIPOCYTE LIPID BINDING PROTEIN COMPLEXED WITH ARACHIDONIC ACID: X-RAY 2 CRYSTALLOGRAPHIC AND TITRATION CALORIMETRY STUDIES,CDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDLVTIRSESTFKNTEISFKLGVEFDEITADDRKVKSIITLDGGALVQVQKWDGKSTTIKRKRDGDKLVVECVMKGVTSTRVYERA,1.0,C4001ADL,14.373392601068709,-0.26943606823488686
75,1d6v,2.0,2000,6.17,Kd=670nM,0.6435332225710904,3486,28,28.564070876101347,CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE 2 ANTIBODY MATURATION,DIKMTQSPSSMYASLGERVTITCKASQDINSYLSWFQQKPGKSPKTLIYRANRLVDGVPSRFSGSGSGQDYSLTISSLEYEDMGIYYCLQYDEFPYTFGSGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNR,1.0,C4001D6V,28.69157036464916,0.12749948854781223
76,1fcz,1.38,2000,9.22,Kd=0.6nM,1.01374477386803,2183,27,8.37146916852971,ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: 2 THE COMPLEX WITH THE PANAGONIST RETINOID BMS181156,SPQLEELITKVSKAHQETFPSLCQLGKYTTNSSADHRVQLDLGLWDKFSELATKCIIKIVEFAKRLPGFTGLSIADQITLLKAACLDILMLRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFAGQLLPLEMDDTETGLLSAICLICGDRMDLEEPEKVDKLQEPLLEALRLYARRRRPSQPYMFPRMLMKITDLRGISTKGAERAITLKMEIPGPMPPLIREMLE,1.0,C4001FCZ,8.775876223217518,0.40440705468780713
77,1fl3,2.45,2000,6.8,Kd=0.16uM,0.8961054607604158,3313,23,22.372930450066583,CRYSTAL STRUCTURE OF THE BLUE FLUORESCENT ANTIBODY (19G2) IN COMPLEX 2 WITH STILBENE HAPTEN AT 277K,AALLESGGGLVKPGGSLKLSCTASGITFSRYIMSWVRQIPEKRLEWVASISSGGITYYPDSVAGRFTISRDNVRNILYLQMSSLRSEDTALYYCARGQGRPYWGQGTSVTVSAAKTTPPSVYPAAPGCGDTTGSSVTLGCLVKGYFPEPVTVTWNSGGSSVHTFPALLQSGLYTMSSSVTVPSSTWPSTVTCSVAHPASSTTVDKKLE,1.0,C4001FL3,21.92484441711722,-0.44808603294936233
78,2qbq,2.1,2008,7.44,Ki=0.036uM,0.7409437318970207,2727,31,14.105663981721255,CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX,MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDL,1.0,C4002QBQ,14.108305533340626,0.002641551619371185
79,2fqx,1.7,2006,7.15,Kd=71nM,0.9555915866833588,2628,20,5.763731485816646,PNRA FROM TREPONEMA PALLIDUM COMPLEXED WITH GUANOSINE,EGGDFVVGMVTDSGDIDDKSFNQQVWEGISRFAQENNAKCKYVTASTDAEYVPSLSAFADENMGLVVACGSFLVEAVIETSARFPKQKFLVIDAVVQDRDNVVSAVFGQNEGSFLVGVAAALKAKEAGKSAVGFIVGMELGMMPLFEAGFEAGVKAVDPDIQVVVEVANTFSDPQKGQALAAKLYDSGVNVIFQVAGGTGNGVIKEARDRRLNGQDVWVIGVDRDQYMDGVYDGSKSVVLTSMVKRADVAAERISKMAYDGSFPGGQSIMFGLEDKAVGIPEENPNLSSAVMEKIRSFEEKIVSKEIVVPVRSARMMN,1.0,C4002FQX,5.6451020515270365,-0.11862943428960993
80,1xhy,1.85,2005,6.18,Ki=662nM,0.9638164936938614,4775,15,16.379989620507143,X-RAY STRUCTURE OF THE Y702F MUTANT OF THE GLUR2 LIGAND-BINDING CORE 2 (S1S2J) IN COMPLEX WITH KAINATE AT 1.85 A RESOLUTION,GANKTVVVTTILESPYVMMKKNHEMLEGNERYEGYCVDLAAEIAKHCGFKYKLTIVGDGKYGARDADTKIWNGMVGELVYGKADIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKGTPIESAEDLSKQTEIAYGTLDSGSTKEFFRRSKIAVFDKMWTYMRSAEPSVFVRTTAEGVARVRKSKGKYAFLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSSLGNAVNLAVLKLNEQGLLDKLKNKWWYDKGECGS,0.9734848484848484,C4001XHY,16.463769474043563,0.08377985353642003
81,1jqy,2.14,2002,4.92,Ki=12uM,0.6838707100918523,4620,33,27.61345946177745,HEAT-LABILE ENTEROTOXIN B-PENTAMER WITH LIGAND BMSC-0010,APQTITELCSEYRNTQIYTINDKILSYTESMAGKREMVIITFKSGETFQVEVPGSQHIDSQKKAIERMKDTLRITYLTETKIDKLCVWNNKTPNSIAAISMKN,1.0,C4001JQY,27.88550575372776,0.2720462919503106
82,1f4x,2.3,2000,5.59,Kd=2.6uM,0.7711380042560746,3231,20,29.91315622431001,CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST 2 VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN,QAVVTQESALTTSPGETVTLTCRSSTGTVTTSNYANWVQEKPDHLFTGLIGATNNRAAGVPVRFSGSLIGGKAALTITGAQTEDEAIYFCALWYSGHWVFGGGTKLTVLGQPKSSPSVTLFPPSSEELETNKATLVCTITDFYPGVVTVDWKVDGTPVTQGMETTNPSKQSNNKYMASSYLTLTARAWERHSSYSCQVTHEGHTVEKSLS,1.0,C4001F4X,30.66811499415832,0.754958769848308
83,1no6,2.4,2003,4.41,Ki=39uM,0.7233760857908847,2584,25,12.1221137336302,"POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR COMPOUND 5 2 USING A LINKED-FRAGMENT STRATEGY",MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN,0.9963636363636365,C4001NO6,12.513841274130112,0.391727540499911
84,1enu,1.95,2000,5.08,Ki=8.3uM,0.915462034588383,3372,13,9.050827532683815,A NEW TARGET FOR SHIGELLOSIS: RATIONAL DESIGN AND CRYSTALLOGRAPHIC 2 STUDIES OF INHIBITORS OF TRNA-GUANINE TRANSGLYCOSYLASE,MVEATAQETDRPRFSFSIAAREGKARTGTIEMKRGVIRTPAFMPVGTAATVKALKPETVRATGADIILGNTYHLMLRPGAERIAKLGGLHSFMGWDRPILTDSGGYQVMSLSSLTKQSEEGVTFKSHLDGSRHMLSPERSIEIQHLLGSDIVMAFDECTPYPATPSRAASSMERSMRWAKRSRDAFDSRKEQAENAALFGIQQGSVFENLRQQSADALAEIGFDGYAVGGLAVGEGQDEMFRVLDFSVPMLPDDKPHYLMGVGKPDDIVGAVERGIDMFDCVLPTRSGRNGQAFTWDGPINIRNARFSEDLKPLDSECHCAVCQKWSRAYIHHLIRAGEILGAMLMTEHNIAFYQQLMQKIRDSISEGRFSQFAQDFRARYFARNS,1.0,C4001ENU,9.31294027254602,0.2621127398622054
85,2gss,1.9,1997,4.94,Ki=11.5uM,0.5914987345834336,3608,19,17.726022247754145,HUMAN GLUTATHIONE S-TRANSFERASE P1-1 IN COMPLEX WITH 2 ETHACRYNIC ACID,PPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ,1.0,C4002GSS,19.921714915275647,2.1956926675215023
86,2qbu,2.1,2008,6.19,Kd=0.645uM,1.0426207232068714,3952,26,11.27844106671522,CRYSTAL STRUCTURE OF METHANOTHERMOBACTER THERMAUTOTROPHICUS CBIL,MHGKLIGVGVGPGDSELLTLRAVNVLRSVPVICAPRSSSERESIALSIVEDILTERRDGCRILDPVFPMTDDRDELESHWDSAARMVAAELEDGRDVAFITLGDPSIYSTFSYLQQRIEDMGFKTEMVPGVTSFTACAATAGRTLVEGDEILLVVPRVDDRFERVLRDVDACVIMKTSRHGRRAMEVVESDPRGKDVVSVANCSMDDEVVERGFASGGGYLATTLVRFREQS,1.0,C4002QBU,11.442978475471133,0.16453740875591194
87,1td7,2.5,2004,4.37,Kd=43uM,0.7349335907397679,1036,20,7.656244371894802,INTERACTIONS OF A SPECIFIC NON-STEROIDAL ANTI-INFLAMMATORY 2 DRUG (NSAID) WITH GROUP I PHOSPHOLIPASE A2 (PLA2): CRYSTAL 3 STRUCTURE OF THE COMPLEX FORMED BETWEEN PLA2 AND NIFLUMIC 4 ACID AT 2.5 A RESOLUTION,NLYQFKNMIQCTVPSRSWQDFADYGCYCGKGGSGTPVDDLDRCCQVHDNCYNEAENISGCRPYFKTYSYECTQGTLTCKGDNNACAASVCDCDRLAAICFAGAPYNDANYNIDLKARCN,1.0,C4001TD7,10.997225498231511,3.3409811263367093
88,1oyq,1.9,2003,6.96,Ki=110nM,0.6130058791751913,1838,39,14.73891699594695,TRYPSIN INHIBITOR COMPLEX,IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN,1.0,C4001OYQ,14.779530282094557,0.0406132861476074
89,1p1o,1.6,2003,5.76,Kd=1.74uM,1.0783319866645844,4375,13,15.62939553822158,CRYSTAL STRUCTURE OF THE GLUR2 LIGAND-BINDING CORE (S1S2J) MUTANT 2 L650T IN COMPLEX WITH QUISQUALATE,GANKTVVVTTILESPYVMMKKNHEMLEGNERYEGYCVDLAAEIAKHCGFKYKLTIVGDGKYGARDADTKIWNGMVGELVYGKADIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKGTPIESAEDLSKQTEIAYGTTDSGSTKEFFRRSKIAVFDKMWTYMRSAEPSVFVRTTAEGVARVRKSKGKYAYLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSSLGNAVNLAVLKLNEQGLLDKLKNKWWYDKGECGS,0.9923076923076924,C4001P1O,15.514184437443612,-0.1152111007779677
90,1k4h,1.8,2002,5.11,Ki=7.7uM,0.8415193913206477,3327,18,7.637269190654335,"CRYSTAL STRUCTURE OF TRNA-GUANINE TRANSGLYCOSYLASE (TGT) COMPLEXED 2 WITH 2,6-DIAMINO-8-PROPYLSULFANYLMETHYL-3H-QUINAZOLINE-4-ONE",MVEATAQETDRPRFSFSIAAREGKARTGTIEMKRGVIRTPAFMPVGTAATVKALKPETVRATGADIILGNTYHLMLRPGAERIAKLGGLHSFMGWDRPILTDSGGYQVMSLSSLTKQSEEGVTFKSHLDGSRHMLSPERSIEIQHLLGSDIVMAFDECTPYPATPSRAASSMERSMRWAKRSRDAFDSRKEQAENAALFGIQQGSVFENLRQQSADALAEIGFDGYAVGGLAVGEGQDEMFRVLDFSVPMLPDDKPHYLMGVGKPDDIVGAVERGIDMFDCVLPTRSGRNGQAFTWDGPINIRNARFSEDLKPLDSECHCAVCQKWSRAYIHHLIRAGEILGAMLMTEHNIAFYQQLMQKIRDSISEGRFSQFAQDFRARYFARNS,1.0,C4001K4H,8.17573880400848,0.5384696133541453
91,1ejn,1.8,2000,5.62,Ki=2.4uM,0.8931172190784156,2138,25,10.041272126031032,UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN INHIBITOR COMPLEX,IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL,1.0,C4001EJN,10.056730712068282,0.015458586037249589
92,2std,2.1,1999,9.85,Ki=0.14nM,0.9903588463287024,4571,20,18.13864944001378,SCYTALONE DEHYDRATASE COMPLEXED WITH TIGHT-BINDING INHIBITOR 2 CARPROPAMID,MGSQVQKSDEITFSDYLGLMTCVYEWADSYDSKDWDRLRKVIAPTLRIDYRSFLDKLWEAMPAEEFVGMVSSKQVLGDPTLRTQHFIGGTRWEKVSEDEVIGYHQLRVPHQRYKDTTMKEVTMKGHAHSANLHWYKKIDGVWKFAGLKPDIRWGEFDFDRIFEDGRETFGDK,0.9629629629629628,C4002STD,18.357172629825733,0.21852318981195396
93,1od8,1.05,2003,5.1,Ki=8uM,0.831342237148471,2971,18,9.802610624765324,XYLANASE XYN10A FROM STREPTOMYCES LIVIDANS IN COMPLEX WITH XYLOBIO- 2 ISOFAGOMINE LACTAM,AESTLGAAAAQSGRYFGTAIASGRLSDSTYTSIAGREFNMVTAENEMKIDATEPQRGQFNFSSADRVYNWAVQNGKQVRGHTLAWHSQQPGWMQSLSGSALRQAMIDHINGVMAHYKGKIVQWDVVNEAFADGSSGARRDSNLQRSGNDWIEVAFRTARAADPSAKLCYNDYNVENWTWAKTQAMYNMVRDFKQRGVPIDCVGFQSHFNSGSPYNSNFRTTLQNFAALGVDVAITELDIQGAPASTYANVTNDCLAVSRCLGITVWGVRDSDSWRSEQTPLLFNNDGSKKAAYTAVLDALNGGDSSEPPADGG,0.9966329966329966,C4001OD8,9.964332848340902,0.16172222357557864
94,1zog,2.3,2005,7.15,Ki=70nM,0.7212754613435847,5789,15,30.231889364278675,CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB- 2 DERIVATIVES,MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVRAAENSRTRA,0.963076923076923,C4001ZOG,30.11236166973789,-0.11952769454078549
95,1lee,1.9,2002,7.74,Ki=18nM,0.7968362513744397,2993,39,8.313671323477605,CRYSTAL STRUCTURE OF PLASMEPSIN FROM P. FALCIPARUM IN COMPLEX WITH 2 INHIBITOR RS367,LGSSNDNIELVDFQNIMFYGDAEVGDNQQPFTFILDTGSANLWVPSVKCTTAGCLTKHLYDSSKSRTYEKDGTKVEMNYVSGTVSGFFSKDLVTVGNLSLPYKFIEVIDTNGFEPTYTASTFDGILGLGWKDLSIGSVDPIVVELKNQNKIENALFTFYLPVHDKHTGFLTIGGIEERFYEGPLTYEKLNHDLYWQITLDAHVGNISLEKANCIVDSGTSAITVPTDFLNKMLQNLDVIKVPFLPFYVTLCNNSKLPTFEFTSENGKYTLEPEYYLQHIEDVGPGLCMLNIIGLDFPVPTFILGDPFMRKYFTVFDYDNHSVGIALAKKNL,1.0,C4001LEE,8.482937062762534,0.1692657392849295
96,3b66,1.65,2008,8.6,Ki=2.5nM,1.0590782101898852,2205,29,8.583472611056848,CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING 2 DOMAIN IN COMPLEX WITH SARM S-21,PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ,1.0,C4003B66,8.623789303626163,0.04031669256931458
97,2f1g,1.9,2006,7.54,Ki=29nM,0.7071767518226442,1907,32,12.420601594162983,CATHEPSIN S IN COMPLEX WITH NON-COVALENT 2-(BENZOXAZOL-2-YLAMINO)- 2 ACETAMIDE,NRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI,1.0,C4002F1G,12.422983147764937,0.0023815536019533567
98,2exm,1.8,2005,4.11,Ki=78uM,0.7984099778424669,2512,15,12.877383118768106,HUMAN CDK2 IN COMPLEX WITH ISOPENTENYLADENINE,MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL,1.0,C4002EXM,12.96029564447811,0.08291252571000385
99,1vyf,1.85,2004,8.05,Kd=9nM,0.741090032791994,1240,20,6.386027289618679,SCHISTOSOMA MANSONI FATTY ACID BINDING PROTEIN IN COMPLEX 2 WITH OLEIC ACID,GSMSSFLGKWKLSESHNFDAVMSKLGVSWATRQIGNTVTPTVTFTMDGDKMTMLTESTFKNLSCTFKFGEEFDEKTSDGRNVKSVVEKNSESKLTQTQVDPKNTTVIVREVDGDTMKTTVTVGDVTAIRNYKRLS,1.0,C4001VYF,6.586834612306404,0.2008073226877256
100,2e7f,2.2,2007,6.1,Kd=0.79uM,0.7107314552578048,4464,33,21.33580627327564,5-METHYLTETRAHYDROFOLATE CORRINOID/IRON SULFUR PROTEIN 2 METHYLTRANSFERASE COMPLEXED WITH METHYLTETRAHYDROFOLATE TO 3 2.2 ANGSROM RESOLUTION,MLIIGERINGMFGDIKRAIQERDPAPVQEWARRQEEGGARALDLNVGPAVQDKVSAMEWLVEVTQEVSNLTLCLDSTNIKAIEAGLKKCKNRAMINSTNAEREKVEKLFPLAVEHGAALIGLTMNKTGIPKDSDTRLAFAMELVAAADEFGLPMEDLYIDPLILPANVAQDHAPEVLKTLQQIKMLADPAPKTVLGLSNVSQNCQNRPLINRTFLAMAMACGLDAAIADACDEALIETAATAEILLNQTVYCDSFVKMFKTR,1.0,C4002E7F,22.63038078100567,1.2945745077300295
101,1bgq,2.5,1999,8.57,Kd=2.7nM,0.8232612183920766,3607,25,20.851389218241984,RADICICOL BOUND TO THE ATP BINDING SITE OF THE N-TERMINAL 2 DOMAIN OF THE YEAST HSP90 CHAPERONE,MRGSHHHHHHGMASETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLETEPDLFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSGTKAFMEALSAGADVSMIGQFGVGFYSLFLVADRVQVISKSNDDEQYIWESNAGGSFTVTLDEVNERIGRGTILRLFLKDDQLEYLEEKRIKEVIKRHSEFVAYPIQLVVTKEVE,0.9953271028037384,C4001BGQ,20.89374403706132,0.042354818819337225
102,1h22,2.15,2002,9.1,Ki=0.8nM,0.876322280287965,4428,34,12.058581739298212,"STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH (S,S)- 2 (-)-BIS(10)-HUPYRIDONE AT 2.15A RESOLUTION",DDHSELLVNTKSGKVMGTRVPVLSSHISAFLGIPFAEPPVGNMRFRRPEPKKPWSGVWNASTYPNNCQQYVDEQFPGFSGSEMWNPNREMSEDCLYLNIWVPSPRPKSTTVMVWIYGGGFYSGSSTLDVYNGKYLAYTEEVVLVSLSYRVGAFGFLALHGSQEAPGNVGLLDQRMALQWVHDNIQFFGGDPKTVTIFGESAGGASVGMHILSPGSRDLFRRAILQSGSPNCPWASVSVAEGRRRAVELGRNLNCNLNSDEELIHCLREKKPQELIDVEWNVLPFDSIFRFSFVPVIDGEFFPTSLESMLNSGNFKKTQILLGVNKDEGSFFLLYGAPGFSKDSESKISREDFMSGVKLSVPHANDLGLDAVTLQYTDWMDDNNGIKNRDGLDDIVGDHNVICPLMHFVNKYTKFGNGTYLYFFNHRASNLVWPEWMGVIHGYEIEFVFGLPLVKELNYTAEEEALSRRIMHYWATFAKTGNPNEPHSQESKWPLFTTKEQKFIDLNTEPMKVHQRLRVQMCVFWNQFLPKLLNATACDGELSS,0.9142380183880288,C4001H22,14.56909322937439,2.510511490076178
103,2boh,2.2,2006,8.52,Ki=3nM,0.8321817583258446,2504,33,16.69226138179472,"CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND ""1"" REVDAT   3   29-JAN-14 2BOH    1       TITLE  REMARK VERSN  HETSYN",EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER,0.9929328621908128,C4002BOH,16.868113603511237,0.17585222171651793
104,3d7z,2.1,2008,7.92,Ki=12nM,0.971609295919833,3209,26,9.865896692840147,CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIPHENYL AMIDE 2 INHIBITOR,MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES,1.0,C4003D7Z,9.884303909271267,0.018407216431119977
105,2psv,1.75,2007,7.24,Ki=58nM,0.9272223864138328,1716,33,4.984362094406492,CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH CARB- 2 KB45,PQITLWKRPLVTIRIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIGGFIKVRQYDQIPIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF,1.0,C4002PSV,5.257820998025093,0.27345890361860103
106,1ele,2.0,1995,6.85,Ki=0.14uM,0.7044020550029166,1989,29,13.376686028158607,STRUCTURAL ANALYSIS OF THE ACTIVE SITE OF PORCINE PANCREATIC ELASTASE 2 BASED ON THE X-RAY CRYSTAL STRUCTURES OF COMPLEXES WITH 3 TRIFLUOROACETYL-DIPEPTIDE-ANILIDE INHIBITORS,VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVVVGEHNLNQNNGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAGGDGVRSGCQGDSGGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINNVIASN,1.0,C4001ELE,13.095439767866528,-0.2812462602920789
107,1hmt,1.4,1995,5.79,Kd=1.64uM,0.7715577658398385,1238,20,6.883783920168359,1.4 ANGSTROMS STRUCTURAL STUDIES ON HUMAN MUSCLE FATTY ACID BINDING 2 PROTEIN: BINDING INTERACTIONS WITH THREE SATURATED AND UNSATURATED 3 C18 FATTY ACIDS,VDAFLGTWKLVDSKNFDDYMKSLGVGFATRQVASMTKPTTIIEKNGDILTLKTHSTFKNTEISFKLGVEFDETTADDRKVKSIVTLDGGKLVHLQKWDGQETTLVRELIDGKLILTLTHGTAVCTRTYEKEA,1.0,C4001HMT,7.200491645054422,0.31670772488606325
